Efficacy and Safety Profile of Combining Sorafenib with Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer: A Meta-analysis
about
Sorafenib in breast cancer treatment: A systematic review and overview of clinical trialsSorafenib: 10 years after the first pivotal trial.A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO).Sorafenib for the treatment of breast cancer.
P2860
Efficacy and Safety Profile of Combining Sorafenib with Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer: A Meta-analysis
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Efficacy and Safety Profile of ...... Breast Cancer: A Meta-analysis
@en
type
label
Efficacy and Safety Profile of ...... Breast Cancer: A Meta-analysis
@en
prefLabel
Efficacy and Safety Profile of ...... Breast Cancer: A Meta-analysis
@en
P2093
P2860
P356
P1476
Efficacy and Safety Profile of ...... Breast Cancer: A Meta-analysis
@en
P2093
Chun-Xiang Tian
Nan-Sheng Cheng
P2860
P356
10.4048/JBC.2014.17.1.61
P577
2014-03-28T00:00:00Z